One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   North America Negative Pressure Wound Therapy Market

[ 英語タイトル ] North America Negative Pressure Wound Therapy Market - Growth, Trends, and Forecasts (2020 – 2025)

Product Code : MDHC0088974
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 92
Category : Healthcare and Pharmaceuticals
Study Area : North America
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3750 / Question Form
5 User USD4250 / Question Form
Enterprise User USD7000 / Question Form
 - Molnlycke Health Care
- ConvaTec Inc.
- Cardinal Health, Inc.
- Smith & Nephew plc
- 3M (Acelity L.P. Inc.)
- Talley Group Limited
- Devon Medical, Inc
- Medela AG
- DeRoyal Industries, Inc.

[Report Description]

The negative pressure wound therapy is considered to be the most preferred choice of treatment, especially for deep acute wounds and persistent chronic wounds including leg ulcers. The topical use of NPWT has been widely studied in the literature over the past 20 years. Most clinical trials have shown the effectiveness of this therapy in the treatment of superficial wounds. Moreover, the localized use of NPWT in infected wounds offers advantages, such as wound drainage, angiogenesis stimulation, proteinase excretion, and decreased local and systemic bacterial load. The increasing prevalence of chronic wounds and diabetic ulcers in the region and technological advancements in the NPWT devices are fueling the market growth.

The United States National Institutes of Health, report published in 2017, states that chronic wounds, or wounds that are slow to heal affect 6.5 million people in the country currently. However, the high cost of the treatment and complications associated with NPWT devices are the major restraints for the growth of the market in the region.

Key Market Trends

Diabetic Foot Ulcers are Expected to Witness Rapid Growth in the Market Studied

Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and is posing a burden on several countries across the region. According to the Centers for Disease Control and Prevention, 2017, every year about 73,000 amputations of the lower limb not related to trauma are performed on people with diabetes, in the United States. With the increasing rise in the prevalence of diabetes in the region, the foot ulcers are also on a hike, as 10% of people with diabetes have a foot ulcer.

Several studies have revealed that NPWT is helpful in reducing the time it takes wounds to heal. Faster wound healing results in an overall decrease in hospitalization and avoids the additional morbidity of chronic wounds. Hence, due to the efficacy of the NPWT in healing the DFU in less time, the demand for NPWT is increasing despite the high price of it. Added to that, rising incidence and prevalence of DFU across the region are fuelling the segment growth.

Competitive Landscape

The North America Negative Pressure Wound Therapy Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are Molnlycke Health Care, ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, 3M Company.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Accidents and Traumatic Events
4.2.2 Rising Chronic Wounds Such as Diabetic Foot Ulcers
4.2.3 Technological Advancements in the NPWT Devices
4.3 Market Restraints
4.3.1 High Cost of Device and Treatment
4.3.2 Complications Associated With NPWT Device
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Re-Usable Device
5.1.2 Single-Use Device
5.2 By Wound Type
5.2.1 Diabetic Foot Ulcer
5.2.2 Pressure Ulcer
5.2.3 Venous Leg Ulcer
5.2.4 Burn Wounds
5.2.5 Others
5.3 By End-User
5.3.1 Hospital
5.3.2 Homecare
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico

6.1 Company Profiles
6.1.1 Molnlycke Health Care
6.1.2 ConvaTec Inc.
6.1.3 Cardinal Health, Inc.
6.1.4 Smith & Nephew plc
6.1.5 3M (Acelity L.P. Inc.)
6.1.6 Talley Group Limited
6.1.7 Devon Medical, Inc
6.1.8 Medela AG
6.1.9 DeRoyal Industries, Inc.




Recommended reports